The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
5018 2018 An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
3074 2018 Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
2833 2018 Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2 ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ...
The Journal of clinical endocrinology & metabolism 86 (12), 5658-5671, 2001
2616 2001 Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
2430 2018 Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
2274 2018 Phaeochromocytoma JWM Lenders, G Eisenhofer, M Mannelli, K Pacak
The Lancet 366 (9486), 665-675, 2005
2234 2005 Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
1852 2018 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients GP Rossi, G Bernini, C Caliumi, G Desideri, B Fabris, C Ferri, C Ganzaroli, ...
Journal of the American College of Cardiology 48 (11), 2293-2300, 2006
1822 2006 Germ-line mutations in nonsyndromic pheochromocytoma HPH Neumann, B Bausch, SR McWhinney, BU Bender, O Gimm, ...
New England Journal of Medicine 346 (19), 1459-1466, 2002
1732 2002 Biochemical diagnosis of pheochromocytoma: which test is best? JWM Lenders, K Pacak, MCM Walther, WM Linehan, M Mannelli, ...
Jama 287 (11), 1427-1434, 2002
1673 2002 Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
1014 2018 Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
985 2018 Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
951 2018 The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
926 2018 Adjuvant mitotane treatment for adrenocortical carcinoma M Terzolo, A Angeli, M Fassnacht, F Daffara, L Tauchmanova, PA Conton, ...
New England Journal of Medicine 356 (23), 2372-2380, 2007
903 2007 Search for physics beyond the standard model in dilepton mass spectra in proton-proton collisions at V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, T Bergauer, ...
Journal of High Energy Physics 2015 (4), 1-49, 2015
848 * 2015 Pheochromocytoma: recommendations for clinical practice from the First International Symposium K Pacak, G Eisenhofer, H Ahlman, SR Bornstein, AP Gimenez-Roqueplo, ...
Nature clinical practice Endocrinology & metabolism 3 (2), 92-102, 2007
847 2007 Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ...
Cancer cell 34 (2), 211-224. e6, 2018
840 2018 Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
793 2018 